IGF1 and cancer: Low levels of anabolic hormones (testosterone, growth hormone, insulin-like growth factor (IGF-1)), altered insulin production and tissue sensitivity to insulin, high levels of myostatin and high levels of inflammatory cytokines (TNFα, IL-6) are considered the main endocrine-system hypo-anabolic factors likely to drive cancer cachexia [9].